Role of Melatonin in the Onset of Metabolic Syndrome in Men

Section: Research Paper
Issue
Vol. 21 No. 2 (2024): Volume 21 Issue 2
Published
Jun 1, 2024
Pages
66-71

Abstract

Background: This prospective hospital-based study conducted in Tikrit City (Iraq) aimed to investigate the role of melatonin and the level of haemoglobin A1c and lipid profile concentrations in metabolic syndrome patients. The present study sought to identify the role of serum melatonin in MetS male patients. Methods: Participants were all males aged 18-50 years. A total of 60 metabolic syndrome male patients versus 30 healthy control male participants were enrolled in the present study. Blood samples were collected at a specific time (10 P.M. to 1 A.M.) and analyzed for measurement of haemoglobin A1c, lipid profile and melatonin. Results: Melatonin is significantly (p>0.001) lower in patients with metabolic syndrome (206.55 105 pg/ml) compared with the control group (298.82110.4 pg/ml). The metabolic syndrome has significantly (p >0.001) elevated HbA1c % and lipid profile compared with the control group. Conclusion: In metabolic syndrome patients, serum melatonin concentration is reduced alongside elevated lipid profile glycemic control compared to normal people, these characteristics could participate in further enhancing the underlying pathology of metabolic syndrome diseases.

References

  1. Asato CB, Nelson-Hurwitz DC, Lee T, Grandinetti A. Comparative analysis of metabolic syndrome diagnostic criteria and its effects on prevalence in a multiethnic population. Metabolic Syndrome and Related Disorders. 2021;19(6):347-51.
  2. Boiko DI, Shkodina AD, Hasan MM, Bardhan M, Kazmi SK, Chopra H, et al. Melatonergic receptors (Mt1/Mt2) as a potential additional target of novel drugs for depression. Neurochemical Research. 2022;47(10):2909-24.
  3. Cardinali DP, Hardeland R. Inflammaging, metabolic syndrome and melatonin: a call for treatment studies. Neuroendocrinology. 2017;104(4):382-97.
  4. Cardinali DP, Scacchi Bernasconi PA, Reynoso R, Reyes Toso CF, Scacchi P. Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats. International Journal of Molecular Sciences. 2013;14(2):2502-14.
  5. Chan K, Wong FS, Pearson JA. Circadian rhythms and pancreas physiology: A review. Frontiers in Endocrinology. 2022;13:920261.
  6. Ciortea R, Costin N, Braicu I, Harag D, Hudacsko A, Bondor C, et al. Effect of melatonin on intra-abdominal fat in correlation with endometrial proliferation in ovariectomized rats. Anticancer research. 2011;31(8):2637-43.
  7. Corbaln-Tutau D, Madrid JA, Nicols F, Garaulet M. Daily profile in two circadian markers melatonin and cortisol and associations with metabolic syndrome components. Physiology & behavior. 2014;123:231-5.
  8. Demirtas CY, Pasaoglu OT, Bircan FS, Kantar S, Turkozkan N. The investigation of melatonin effect on liver antioxidant and oxidant levels in fructose-mediated metabolic syndrome model. European Review for Medical and Pharmacological Sciences. 2015;19(10):1915-21.
  9. DomnguezRodrguez A, AbreuGonzlez P, Garca MJ, Sanchez J, Marrero F, ArmasTrujillo DD. Decreased nocturnal melatonin levels during acute myocardial infarction. Journal of pineal research. 2002;33(4):248-52.
  10. Farid A, Moussa P, Youssef M, Haytham M, Shamy A, Safwat G. Melatonin relieves diabetic complications and regenerates pancreatic beta cells by the reduction in NF-kB expression in streptozotocin induced diabetic rats. Saudi journal of biological sciences. 2022;29(7):103313.
  11. Goyal A, Terry PD, Superak HM, Nell-Dybdahl CL, Chowdhury R, Phillips LS, et al. Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial. Diabetology & metabolic syndrome. 2014;6:1-1.
  12. Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, et al. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World Journal of Hepatology. 2013;5(4):160.
  13. Horodincu L, Solcan C. Influence of different light spectra on melatonin synthesis by the pineal gland and influence on the immune system in chickens. Animals. 2023;13(13):2095.
  14. Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi medical journal. 2006;27(10):1483.
  15. Jepsen S, Suvan J, Deschner J. The association of periodontal diseases with metabolic syndrome and obesity. Periodontology 2000. 2020;83(1):125-53.
  16. Kozirg M, Poliwczak AR, Duchnowicz P, KoterMichalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. Journal of pineal research. 2011;50(3):261-6.
  17. Ladizesky MG, Boggio V, Albornoz LE, Castrilln PO, Mautalen C, Cardinali DP. Melatonin increases oestradiolinduced bone formation in ovariectomized rats. Journal of pineal research. 2003;34(2):143-51.
  18. Modabbernia A, Heidari P, Soleimani R, Sobhani A, Roshan ZA, Taslimi S, et al. Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study. Journal of psychiatric research. 2014;53:133-40.
  19. Mostafavi A, Solhi M, Mohammadi MR, Hamedi M, Keshavarzi M, Akhondzadeh S. Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial. Acta Medica Iranica. 2014:734-9.
  20. Nagagata BA, Ajackson M, Ornellas F, Mandarim-de-Lacerda CA, Aguila MB. Obese mothers supplemented with melatonin during gestation and lactation ameliorate the male offsprings pancreatic islet cellular composition and beta-cell function. Journal of Developmental Origins of Health and Disease. 2023;14(4):490-500.
  21. Nduhirabandi F, Du Toit EF, Blackhurst D, Marais D, Lochner A. Chronic melatonin consumption prevents obesityrelated metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of dietinduced obesity. Journal of pineal research. 2011;50(2):171-82.
  22. Obayashi K, Saeki K, Iwamoto J, Okamoto N, Tomioka K, Nezu S, et al. Nocturnal urinary melatonin excretion is associated with non-dipper pattern in elderly hypertensives. Hypertension Research. 2013;36(8):736-40.
  23. Pai SA, Majumdar AS. Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. Journal of Pharmacy and Pharmacology. 2014;66(12):1710-21.
  24. Peschke E, Stumpf I, Bazwinsky I, Litvak L, Dralle H, Mhlbauer E. Melatonin and type 2 diabetesa possible link?. Journal of pineal research. 2007;42(4):350-8.
  25. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, et al. Variants in MTNR1B influence fasting glucose levels. Nature genetics. 2009;41(1):77-81.
  26. Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 2003;144(12):5347-52.
  27. Puchalski SS, Green JN, Rasmussen DD. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. 2003;21:163-7.
  28. Ramirez AV, de S LB. Melatonin and its relationships with diabetes and obesity: a literature review. Current Diabetes Reviews. 2021;17(7):38-50.
  29. RosLugo MJ, Cano P, JimnezOrtega V, FernndezMateos MP, Scacchi PA, Cardinali DP, et al. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fatfed rats. Journal of pineal research. 2010;49(4):342-8.
  30. Romejko K, Markowska M, Niemczyk S. The review of current knowledge on neutrophil gelatinase-associated lipocalin (NGAL). International Journal of Molecular Sciences. 2023;24(13):10470.
  31. Romo-Nava F, Alvarez-Icaza Gonzlez D, Fresn-Orellana A, Saracco Alvarez R, Becerra-Palars C, Moreno J, et al. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, doubleblind, parallelgroup, placebocontrolled clinical trial. Bipolar disorders. 2014;16(4):410-21.
  32. Saleh SS, Sarhat ER. Effects of ethanolic Moringa oleifera extract on melatonin, liver and kidney function tests in alloxan-induced diabetic rats. Indian Journal of Forensic Medicine & Toxicology. 2019;13(4):1015-9.
  33. Sanchez-Mateos S, Alonso-Gonzalez C, Gonzalez A, Martinez-Campa CM, Mediavilla MD, Cos S, et al. Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. Maturitas. 2007;58(1):91-101.
  34. Sarhat ER, Wadi SA, Sedeeq BI, Sarhat TR, Jasim NA. Study of the histopathological and biochemical effect of Punica granatum L. extract on streptozotocin-induced diabetes in rabbits. Iraqi Journal of Veterinary Sciences. 2019;33(1):189-194.
  35. Sarhat KG, Jabir TH. Assessment of melatonin and oxidant-antioxidant markers in infertile men in Thi-Qar Province. Indian Journal of Forensic Medicine & Toxicology. 2019;13(4):1500-4.
  36. Sartori C, Dessen P, Mathieu C, Monney A, Bloch J, Nicod P, et al. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology. 2009;150(12):5311-7.
  37. Song X, Sun X, Ma G, Sun Y, Shi Y, Du Y, et al. Family association study between melatonin receptor gene polymorphisms and polycystic ovary syndrome in Han Chinese. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;195:108-12.
  38. Suriagandhi V, Nachiappan V. Protective effects of melatonin against obesityinduced by leptin resistance. Behavioural brain research. 2022 Jan 24;417:113598.
  39. Tutuncu NB, Batur MK, Yildirir A, Tutuncu T, Deger A, Koray Z, et al. Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. Journal of pineal research. 2005;39(1):43-9.
  40. Yaprak M, Altun A, Vardar A, Aktoz M, Ciftci S, Ozbay G. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. International journal of cardiology. 2003;89(1):103-7.
  41. Zheng C, Dalla Man C, Cobelli C, Groop L, Zhao H, Bale AE, et al. A common variant in the MTNR1b gene is associated with increased risk of impaired fasting glucose (IFG) in youth with obesity. Obesity. 2015;23(5).

Authors

Elham Hasan Mahmood

College of Medicine, Tikrit University, Tikrit, Iraq

ORCID
Nihad Nejres Hilal

College of Medicine, Tikrit University, Tikrit, Iraq

ORCID

Identifiers

Download this PDF file
PDF

Statistics

How to Cite

Hasan Mahmood, E., الهام, Nejres Hilal, N., & نهاد. (2024). Role of Melatonin in the Onset of Metabolic Syndrome in Men. Iraqi Journal of Pharmacy, 21(2), 66–71. Retrieved from https://rjps.uomosul.edu.iq/index.php/iphr/article/view/21631